SYNETS
LIVE

Serial Number

97779299

Owner

Biogency Pty Ltd

Attorney

Jennifer A. Visintine

Filing Date

Feb 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SYNETS Trademark

Serial Number: 97779299 • Registration: 7459948

SYNETS is a trademark filed by Biogency Pty Ltd on February 3, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Biogency Pty Ltd (7 trademarks)

8/36 O'Riordan Street
Alexandra NSW 2015 , AU

Entity Type: 99

Trademark Details

Filing Date

February 3, 2023

Registration Date

July 30, 2024

Published for Opposition

May 14, 2024

Goods & Services

Food supplements, namely, anti-oxidants; Capsules sold empty for pharmaceutical purposes; Capsules sold empty for veterinary pharmaceutical preparations; Chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Collagen based medicated supplements; Decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Antioxidants in the nature of dietary supplements; Dietary protein supplements; Dietary supplements; Dietary supplements for animals; Dietary supplements with a cosmetic effect; Effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Food supplements for medical purposes; Herbal dietary supplements; Dietary nutritional supplements; Nutritional supplements; Medicinal plant compounds for use as dietary supplements; Plant compounds for use as veterinary dietary supplements ; Plant extracts being dietary supplements; Medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; Pharmaceutical drugs to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for skin care; Pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Chemical products for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Natural pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Tablets being pharmaceuticals to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Food supplements for animals in the nature of vitamins; Vitamin supplements; Dietary food supplements; Nutritional drinks being dietary food supplements; Food supplements in the nature of dietary supplements

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 30, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2024 CRFA
ASSIGNED TO LIE
Apr 9, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 17, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 12, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 12, 2023 GNSL
SUSPENSION LETTER WRITTEN
Nov 12, 2023 CNSL
EXAMINER'S AMENDMENT ENTERED
Nov 8, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 8, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 8, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 8, 2023 CNEA
ASSIGNED TO EXAMINER
Nov 1, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2023 NWOS
NEW APPLICATION ENTERED
Feb 7, 2023 NWAP